Single Patient IND in Jordan
How the single patient ind pathway operates in Jordan.
About Single Patient IND
US FDA single-patient Investigational New Drug authorization.
How Single Patient IND works in Jordan
Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.
Patients in Jordan seeking access under Single Patient IND typically follow this flow: a licensed physician in Jordan issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Jordan
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.